In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness

BACKGROUND: Beyond its possible correlation with stemness of tumor cells, CD133/prominin1 is considered an important marker in breast cancer, since it correlates with tumor size, metastasis and clinical stage of triple-negative breast cancers (TNBC), to date the highest risk breast neoplasia. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Brugnoli, Federica, Grassilli, Silvia, Piazzi, Manuela, Palomba, Maria, Nika, Ervin, Bavelloni, Alberto, Capitani, Silvano, Bertagnolo, Valeria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866498/
https://www.ncbi.nlm.nih.gov/pubmed/24330829
http://dx.doi.org/10.1186/1476-4598-12-165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866498/
https://www.ncbi.nlm.nih.gov/pubmed/24330829
http://dx.doi.org/10.1186/1476-4598-12-165

Ejemplares similares